Filter
482
Filtered Results: 482
Text search:
Garcia,
P.J.
Featured
Recommendations
43
New Publications
72
Language
Document type
No document type
208
Studies & Reports
121
Guidelines
88
Manuals
26
Fact sheets
18
Strategic & Response Plan
12
Training Material
7
Resource Platforms
1
Infographics
1
Countries / Regions
Latin America and the Carribbean
24
Brazil
19
Russia
19
Global
19
Philippines
9
Western and Central Europe
9
India
8
Colombia
7
Middle East and North Africa
7
Uganda
6
Africa
6
Syria
5
Argentina
5
Ukraine
5
Yemen
5
Eastern Europe
5
Senegal
4
Zambia
4
Kenya
4
Mozambique
4
Venezuela
4
Spain
4
Ghana
3
Zimbabwe
3
Nepal
3
Germany
3
Tanzania
3
South Africa
3
Chile
3
Eastern Europe and Central Asia
3
Vietnam
3
Guinea
2
USA
2
South Sudan
2
Lebanon
2
Indonesia
2
Peru
2
North Macedonia
2
South–East Asia Region
2
Paraguay
2
Georgia
2
North America
2
Portugal
2
Burkina Faso
1
Nigeria
1
Congo, Democratic Republic of
1
Guinea-Bissau
1
Morocco
1
Cameroon
1
Haiti
1
Pakistan
1
Jordan
1
Afghanistan
1
Turkey
1
Egypt
1
Cambodia
1
Thailand
1
Rwanda
1
Bangladesh
1
Sudan
1
Hungary
1
Honduras
1
El Salvador
1
Bolivia
1
Greece
1
Angola
1
Lesotho
1
Mexico
1
Myanmar / Burma
1
Sri Lanka
1
East and Southern Africa
1
West and Central Africa
1
Other region
1
Asia
1
Italy
1
Armenia
1
Canada
1
Estonia
1
Romania
1
Kyrgyzstan
1
Jamaica
1
Belgium
1
France
1
United Kingdom
1
Norway
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
124
Clinical Guidelines
45
Women & Child Health
32
Public Health
29
Key Resources
7
Capacity Building
2
Pharmacy & Technologies
2
Toolboxes
COVID-19
86
HIV
63
Mental Health
51
TB
34
Planetary Health
23
NTDs
19
NCDs
16
Global Health Education
11
AMR
11
Disability
9
Caregiver
9
Refugee
7
Zika
7
Rapid Response
6
Ebola
4
Conflict
4
Health Financing Toolbox
4
Natural Hazards
2
Pharmacy
2
Cholera
1
Washington, D.C., ÉUA, du 26 au 30 septembre 2016
Point 4.10 de l’ordre du jour provisoire
CD55/14 8 juillet 2016
Original : anglais
Washington, D.C., EUA, 26 a 30 de setembro de 2016
Tema 4.10 da agenda provisória
CD55/14 8 de julho de 2016
Original: inglês
Washington, D.C., EUA, del 26 al 30 de septiembre del 2016
Punto 4.10 del orden del día provisional
CD55/14 8 de julio del 2016
Original: inglés
Accessed Febr. 6, 2020
In recognition of the growing problem of antimicrobial resistance (AMR), its increasing threat to human, animal and plant health, and the need for a One Health approach to address this issue, the 39th Session of the Codex Alimentarius Commission (CAC) agreed it was important for the food safety comm...
Supplement Article
WHO Guidelines for HIV PEP • CID 2015:60 (Suppl 3), S161 - S164
Technical report
February 2015
10 May 2021
This scientific brief replaces the WHO Scientific Brief entitled “’Immunity passports’ in the context of COVID-19”, published 24 April 2020.
This update is focused on what is currently understood about SARS-CoV-2 immunity from natural infection. More information about considera...
School health programmes have been demonstrated to be the most cost-effective way to influence health behaviours in young people. The purpose of this two-part handbook is to support schools as they seek to implement interventions aimed at reducing the main modifiable risk behaviours f...
Infection prevention and control (IPC) practices are of critical importance in protecting the function of healthcare services at all levels and mitigating the impact on vulnerable populations. Although the management of possible COVID-19 cases is usually guided by national policies for specific heal...
Breastfeeding is the cornerstone of infant and young child survival, nutrition and development and maternal health. The World Health Organization recommends exclusive breastfeeding for the first 6 months of life, followed by continued breastfeeding with appropriate complementary foods for up to 2 ye...
WHO published guidance for clinicians and health care decision-makers on the use of corticosteroids in patients with COVID-19.
We recommend systemic corticosteroids for the treatment of patients with severe and critical COVID-19. We suggest not to use corticosteroids in the treatment of patients ...
Interim guidance, 6 October 2021
Direct detection of SARS-CoV-2 viral proteins (antigens) in nasal swabs and other respiratory secretions using lateral flow immunoassays (also known as rapid diagnostic tests, RDTs) offers a faster and less expensive method to test for SARS-CoV-2 than the reference ...
Orientação provisória. 2 de setembro de 2020
Questão clínica: Qual é o papel dos corticosteroides sistêmicos no tratamento de pacientes com COVID-19? Público-alvo: O público-alvo consiste principalmente de médicos, seguido por tomadores de decisão na área de saúde.
A framework for planning, developing and implementing solutions with and for young people.
The guidance presented in this document is intended for digital health intervention designers, developers, implementers, researchers and funders. Newcomers to digital health can use it as a start-to-finish pr...
HIV-1 drug resistance (HIVDR) genotyping is an essential component of the WHO global HIVDR surveillance strategy. Plasma “gold standard” specimen type for HIVDR genotyping, but its use may not be feasible in rural, remote areas in low- and middle-income countries, since preparing and storing it ...
The World Health Organization’s comprehensive antenatal care (ANC) guideline WHO recommendations on antenatal care for a positive pregnancy experience was first published in 2016 with the objective of improving the quality of routine health care that all women and adolescent girls receive during p...
Wie die Corona-Pandemie soziale Ungleichheit verschärft und warum wir unsere Wirtschaft gerechter gestalten müssen
The WHO COVID-19 LENS (Living Evidence Synthesis) working group consolidated available evidence, based on rapid reviews of the literature and results of a living systematic review on pregnancy and COVID-19 (up to October 7, 2020), on potential mechanisms of vertical transmission of infectious pathog...
